[HTML][HTML] Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
Abstract Treatment of BRAF-mutant metastatic melanoma with mitogen-activated protein
kinase (MAPK) pathway targeted therapies (BRAF/MEK inhibitors) and immune checkpoint …
kinase (MAPK) pathway targeted therapies (BRAF/MEK inhibitors) and immune checkpoint …
Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
SJ Welsh, H Rizos, RA Scolyer… - European journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Treatment of BRAF-mutant metastatic melanoma with mitogen-activated protein kinase
(MAPK) pathway targeted therapies (BRAF/MEK inhibitors) and immune checkpoint …
(MAPK) pathway targeted therapies (BRAF/MEK inhibitors) and immune checkpoint …
Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
SJ Welsh, H Rizos, RA Scolyer… - European Journal of …, 2016 - europepmc.org
Treatment of BRAF-mutant metastatic melanoma with mitogen-activated protein kinase
(MAPK) pathway targeted therapies (BRAF/MEK inhibitors) and immune checkpoint …
(MAPK) pathway targeted therapies (BRAF/MEK inhibitors) and immune checkpoint …
Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
SJ Welsh, H Rizos, RA Scolyer, GV Long - European Journal of Cancer, 2016 - infona.pl
Treatment of BRAF-mutant metastatic melanoma with mitogen-activated protein kinase
(MAPK) pathway targeted therapies (BRAF/MEK inhibitors) and immune checkpoint …
(MAPK) pathway targeted therapies (BRAF/MEK inhibitors) and immune checkpoint …
Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
SJ Welsh, H Rizos, RA Scolyer… - European Journal of …, 2016 - researchers.mq.edu.au
Abstract Treatment of BRAF-mutant metastatic melanoma with mitogen-activated protein
kinase (MAPK) pathway targeted therapies (BRAF/MEK inhibitors) and immune checkpoint …
kinase (MAPK) pathway targeted therapies (BRAF/MEK inhibitors) and immune checkpoint …
Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
SJ Welsh, H Rizos, RA Scolyer… - European Journal of …, 2016 - ejcancer.com
Abstract Treatment of BRAF-mutant metastatic melanoma with mitogen-activated protein
kinase (MAPK) pathway targeted therapies (BRAF/MEK inhibitors) and immune checkpoint …
kinase (MAPK) pathway targeted therapies (BRAF/MEK inhibitors) and immune checkpoint …
[引用][C] Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
SJ Welsh, H Rizos, RA Scolyer, GV Long - European Journal of Cancer, 2016 - cir.nii.ac.jp
Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …